Preview

Comparison of Medical Device Regulations in Japan, Eu and the Usa

Good Essays
Open Document
Open Document
2355 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Comparison of Medical Device Regulations in Japan, Eu and the Usa
Comparing Medical Device Law & Regulations of Japan, EU and US
Japan Competent Authority, Related Organization Population: 127 million Ministry of Health, Labor and Welfare( MHLW), -Pharmaceutical and Food Safety Bureau, - Office of Medical Device Control - Office of Compliance - Pharmaceutical Affairs office of each Government Prefectures - Review and Audit by Pharmaceutical and Medical Device Agency (PMDA): about 30 specialists Registered Certification Body (RCB) :14 (JQA, TUV/RH , TUV/SUD, BSI, UL, SGS etc) Pharmaceutical Affairs Law (PAL) New PAL promulgated in July 2002, enforced as of April 1, 2005 to harmonize with GHTF and adopt Quality Management System (QMS), and Essential Principles. PAL Enforcement Ordinance, PAL Enforcement Regulation, GQP (Good Quality Practice),GVP (Good Vigilance Practice),QMS (Quality Management System) and GCP (Good Clinical Practice) promulgated in July 2004 – July 2005. Many Ordinances and Notices issued up till now. Transfer of Certification or Approval (KISAI-SEIBI: June 8, 2007) for medical devices approved or notified under Old PAL must be done until the next renewal of license of MAH (2006 – March 2010) Technical Standards (JIS) for Certification (396) , Approval (35) and IVD Reagent Certification (8 groups, 366) The following Licenses are required for MD business, 1. License for Manufacturer (4,269 as of 2007) 2. Accreditation of Foreign Manufacturers (about 1,000) 3. License for Marketing Authorization Holder (MAH: 2,676) who is responsible for marketing medical devices and was Manufacturer or Importer of MDs under Old PAL. 3 controllers are required, Marketing Supervisor, Safety Control manager, Quality Assurance manager (quite unique compared with US, EU) 4. License for Retail and Rental Business of ClassⅡ- Class Ⅳ MDs and Registration for sales of ClassⅠ 5. License for Repair Business of each Technical Support Office MDC Japan April 2008.Medical Device Consulting Japan EU Population: 493 million, 27 countries EC unit

You May Also Find These Documents Helpful

  • Best Essays

    Health law and Regulations

    • 1715 Words
    • 5 Pages

    Health Law and Regulations Bianca Needham September 22, 2014 Professor Kathleen Cross Health Law and Regulations…

    • 1715 Words
    • 5 Pages
    Best Essays
  • Good Essays

    Week 3 Dq 1

    • 362 Words
    • 2 Pages

    For an organization, understanding the issues around regulatory compliance can be a difficult and frustrating attempt. A short-term action an organization has to use to come into regulatory compliance is identifying standards of care. An understanding of professional practices is a key element of the review of professional liability exposures. Knowledge of such standards is crucial in controlling risk during the development and implementation of new and alternative treatment regimens. A long-term action is ensuring that the regulatory approval process is conducted in a timely and cost-effective manner. The primary purpose of measuring consumer satisfaction is to improve the quality of care provided should always be kept in mind. This principle should guide in what data are collected, how they are collected and most importantly, how they are analyzed and reported.…

    • 362 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    Millicent Villamayor – Fadul is an Operating Room nurse with over 20 years of experience as a circulating and charge nurse in various hospitals in the north east. She is currently employed at Medstar Franklin Square Medical Center as an O.R. Nurse Level IV. She is a member of Quality and Safety Committee in the O.R. Department and of widely recognized Association of Operating Room Nurses (AORN). In 2012, she initiated the Allograft tissue tracking system after the department was cited by Joint Commission for non-compliance of proper documentation of allograft tissue tracking. She developed a tissue tracking system using excel spreadsheet to ensure documentation compliance. She audits the tracking system monthly, rectify any error, re-educate staff who makes a wrong entry and report the progress to the nurse manager. Moreover, she with the help of the clinical educator came up with an E-Learning course on how to properly handle and process allograft tissues. The E-Learning module was loaded in their Learning System Management and being used as an annual mandatory course for the staff. For three consecutive years after initiating tissue tracking system, the department has not been cited by the Joint Commission.…

    • 278 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Clinical Laboratory Improvement Amendments (CLIA), is regulated by The Centres for Medicare and Medicaid Services. The objective for CLIA program is to ensure quality non-research laboratory testing. CLIA standard is a federal requirement for any entity providing a non-research clinical laboratory test. The passage of CLIA 1998 and the implementation of the regulation in 1993 constituted a vast change in the regulations of clinical laboratories in the United States. There was mixed reaction initially as any regulations guarantees. The different profession had differences of opinion to these changes. From a patient's point of view, it is welcome regulation as they are assured quality standardized laboratory test results. Patients are assured that a laboratory follows proper procedure in regards to the patient's test results. Standard procedure is necessary to get the accurate and reliable and timeliness results.…

    • 324 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Hcs/ 490 Outline

    • 475 Words
    • 2 Pages

    References: Division of Drug Marketing, Advertising, and Communications (DDMAC). 2010. Retrieved August 6, 2010 from http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm090142.htm Food and Drug Administration (2010). Division of Drug, Marketing, Advertising, and Communications. Retrieved from http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm090142.htm Us Food and Drug Administration. (2010). Retrieved August 9, 2010 from website: http://www.fda.gov/AboutFDA/WhatWeDo/default.htm US Food and Drug Administration (2010). “Inspection, Compliance, Enforcement and Criminal Investigations.” Retrieved August 16, 2010 from www.hhs.gov.…

    • 475 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Facility Plan

    • 326 Words
    • 2 Pages

    It is important to communicate with and address the issues raised by stakeholders because protection of public health is the basis for all communication with stakeholders. The information being conveyed is pertinent to the urgent recall of a faulty product or the sharing of new prescribing information. It is both situations are grounded in the regulators key function as a protector of public health. The information and effective communication can assist in the development of a good relationship between the regulatory network, and its environment, and may also assist in influencing the wider environment by informing, and changing attitudes in the various target groups. The reasons to communicate are development of trust, social, responsibility, market transparency, and professional ethics all of which support the overall goal of protecting public health. Changes in society and technology have brought about new mechanisms to access information on medicines, and medical treatment. Society is more informed on health matters, and the consumer has become more active in treatment, and medication planning. The concept of growing in this world of medical treatment, and will result in a greater demand for quality information.…

    • 326 Words
    • 2 Pages
    Good Essays
  • Powerful Essays

    The Regulations set out a comprehensive regime for the authorisation of medicinal products for human use; for the manufacture, import, distribution, sale and supply of those products; for their labelling and advertising; and for pharmacovigilance. It replaces most of the Medicines Act 1968.…

    • 6478 Words
    • 21 Pages
    Powerful Essays
  • Powerful Essays

    The National Minimum Standards require the registered person puts in place policies and procedures for the receipt, recording, storage, administration and disposal of medicines. These policies and procedures are to protect not only the service users but also the…

    • 3274 Words
    • 14 Pages
    Powerful Essays
  • Good Essays

    I have to comply under the Medicines Act 1968, and under The Royal Pharmaceutical Society guidelines and the Handling Of Medicines act 2007.…

    • 1577 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    These Regulations set out a complex regime for the authorisation of medicinal products for human use, Manufacture, import, distribution, sale and supply of those products. For the labelling and advertising and for drug safety.…

    • 2103 Words
    • 7 Pages
    Powerful Essays
  • Good Essays

    Quality Control Standards: Many products can pass inspection in their home countries but sometimes fail inspection in Japan. European and…

    • 2530 Words
    • 11 Pages
    Good Essays
  • Good Essays

    HSC 3047

    • 2722 Words
    • 8 Pages

    The Medicines Act 1968 and Prescription Only Medicines (Human Use) Order 1997 cover the sale, use and production of medicines. The Medicines and Healthcare Products Regulatory Agency (MHRA) is responsible for regulating medicines in the UK. This includes ensuring that medicines and medical devices are safe and bringing prosecutions when medicines legislation has been broken.…

    • 2722 Words
    • 8 Pages
    Good Essays
  • Satisfactory Essays

    Business Rules

    • 537 Words
    • 3 Pages

    My company, Maquet, is an international medical supply company started in 1853. They began by making operating tables and operating room lamps. Today they make a wide gamut of products from complete operating rooms systems, to balloon pumps and other life-saving equipment. One of our quips is that if you see our equipment, you are really in trouble or you’re a doctor or a nurse. Since we design and manufacture medical supplies, we are regulated by the FDA and are under constant scrutiny and monitoring. Because of this constant…

    • 537 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    Executive Summary..................................................................................................................................... 3 Industry Overview ....................................................................................................................................... 3 Pharmaceutical Industry ......................................................................................................................... 3 Industry Analysis ......................................................................................................................................... 6 Porter’s five forces Model....................................................................................................................... 6 Company Overview ..................................................................................................................................... 7 Cipla Ltd. ................................................................................................................................................. 7 ShareHolding Pattern: Cipla Ltd. ......................................................................................................... 8 Dividend History: Cipla Ltd. ................................................................................................................. 9 Shareholder…

    • 9291 Words
    • 38 Pages
    Good Essays
  • Powerful Essays

    Medical Enhancement

    • 13050 Words
    • 53 Pages

    To be published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section(ii) dated 15th May 2013 Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) New Delhi Dated 15th ___May 2013 25 Vaisakha Saka 1935 ORDER S.O. 1221(E).– In exercise of the powers conferred by section 3 of the Essential Commodities Act, 1955, (10 of 1955), and supersession of the Drug (Prices Control) Order, 1995, except as respect to things done or omitted to be done before such supersession, the Central Government hereby makes the following Order, namely:1. Short title and commencement.– (1) This Order may be called the Drugs (Prices Control) Order, 2013. (2) It shall come into force on the date of its publication in the Official Gazette. 2. Definitions.– (1) In this Order, unless the context otherwise requires,– (a) “Act” means the Essential Commodity Act, 1955 (10 of 1955); (b) "active pharmaceutical ingredients or bulk drug" means any pharmaceutical, chemical, biological or plant product including its salts, esters, isomers, analogues and derivatives, conforming to standards specified in the Drugs and Cosmetics Act, 1940 (23 of 1940) and which is used as such or as an ingredient in any formulation; (c) “brand” means a name, term, design, symbol, trademark or any other feature that identifies one seller’s drug as distinct from those of other sellers;…

    • 13050 Words
    • 53 Pages
    Powerful Essays